This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Naltrexone". See definition (new window)
The effects of naltrexone in autistic children: report of two cases.
Turkish Journal of Pediatrics
37(1), pp. 19-23
Barrett R. P. , Feinstein C. , Hole W. T. (1989)
Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.
American Journal of Mental Retardation
93(6), pp. 644-651
Benjamin S. et al. (1995)
Case study: paradoxical response to naltrexone treatment of self-injurious behavior.
Journal of the American Academy of Child and Adolescent Psychiatry
34(2), pp. 238-242
Black S. L. et al. (1994)
Naltrexone in infantile autism.
Journal of Autism and Developmental Disorders
24(2), pp. 236-239
Brown N. , Panksepp J. (2008)
Low-dose naltrexone for disease prevention and quality of life.
Medical Hypotheses
72(3), pp. 333-337
Buitelaar J. K. , Willemsen-Swinkels S. H. , van Engeland H. (1998)
Naltrexone in children with autism.
Journal of the American Academy of Child and Adolescent Psychiatry
37(8), pp. 800-802
Campbell M. et al. (1990)
Naltrexone in autistic children: a double-blind and placebo-controlled study.
Psychopharmacology Bulletin
26(1), pp. 130-135
Campbell M. et al. (1989)
Naltrexone in autistic children: an acute open dose range tolerance trial.
Journal of the American Academy of Child and Adolescent Psychiatry
28(2), pp. 200-206
Campbell M. et al. (1993)
Naltrexone in autistic children: behavioral symptoms and attentional learning.
Journal of the American Academy of Child and Adolescent Psychiatry
32(6), pp. 1283-1291
Medications for adolescents and young adults with autism spectrum disorders: A systematic review.
Pediatrics
130(4), pp. 717 -726.
Doyle C. A. , McDougle C. J. (2012)
Pharmacotherapy to control behavioral symptoms in children with autism.
Expert Opinion on Pharmacotherapy
13(11), pp. 1615-1629.
ElChaar G. M. et al. (2004)
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.
Mental Retardation and Developmental Disabilities Research Reviews
10(3), pp. 193-200.
Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.
Psychopharmacology Bulletin
29(2), pp. 221-227
Feldman H. M. , Kolmen B. K. , Gonzaga A. M. (1999)
Naltrexone and communication skills in young children with autism.
Journal of the American Academy of Child and Adolescent Psychiatry
38(5), pp. 587-593
Developmental Medicine and Child Neurology
37(3), pp. 239-245
Gonzalez N. M. et al. (1994)
Naltrexone plasma levels, clinical response and effect on weight in autistic children.
Psychopharmacology Bulletin
30(2), pp. 203-208